Results 141 to 150 of about 13,446 (222)

Progression to Radiographic Axial Spondyloarthritis: A Narrative Review on Timeline and Novel Prediction Factors. [PDF]

Int J Mol Sci
Murgu GE, Mihai IR, Rezus C, Burlui MA, Macovei LA, Rezus E.   +5 more
europepmc   +1 more source

Celiac trunk thrombosis and splenic infarction in a patient with ankylosing spondylitis under adalimumab: a case report. [PDF]

Int J Emerg Med
Grundmann E, Maksin J, Ertman D, Feil B.
europepmc   +1 more source

Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension. [PDF]

RMD Open
Navarro-Compán V, Kiltz U, Mease PJ, Dubreuil M, Gaffney K, Deodhar A, de la Loge C, Prajapati C, Kavanagh S, Marzo-Ortega H.   +9 more
europepmc   +1 more source

No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials. [PDF]

Arthritis Res Ther
Ramiro S, Gaillez C, Kiltz U, Gensler LS, Pisal C, Braun J, Ogdie A.   +6 more
europepmc   +1 more source

Management of ankylosing spondylitis/axial spondyloarthritis

, 2015
openaire   +1 more source

Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial.

JAMA Netw Open
Zhu J, Zhao C, Mi C, Liu S, Wu R, Li T, Duan X, Sun L, Yang L, He X, Liu W, Li Y, Ma L, Du H, Liu Y, Chen G, Zhang H, Wang T, Liu X, Shi X, Liu J, Wu H, Sun H, Xue Y, Chai K, Li H, Hu J, Dong F, Lin L, Du Q, Bai X, Huang F.   +31 more
europepmc   +1 more source

Retinal microvascular changes in patients with ankylosing spondylitis receiving biologic therapy: a cross-sectional OCTA study. [PDF]

BMC Ophthalmol
Samanci R, Meydan B, Teberik K, Meydan SU, Ataoglu S.   +4 more
europepmc   +1 more source

Clinical characteristics, disease activity and psychosocial burden of axial spondyloarthritis in Jordan: a multicenter cross-sectional study. [PDF]

Sci Rep
Alnaimat F, Hamdan O, Shaf'ei M, Al-Ghazawi Z, AbuHelal A, Odeh A, Alawneh KM.   +6 more
europepmc   +1 more source

Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab. [PDF]

Arthritis Res Ther
Vladimirova N, Østergaard M, Georgiadis S, Seven S, Møller JM, Jensen B, Østgård R, Poggenborg R, Madsen OR, Hendricks O, Brix L, Pedersen SJ.   +11 more
europepmc   +1 more source